{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:01:43Z","timestamp":1791093703601,"version":"4.1.0"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Little is known about the ocular penetration of amphotericin B (AMB) and its lipid formulations, the current drug of choice in fungal endophthalmitis. The ocular distribution of AMB lipid complex (ABLC), liposomal AMB (L-AMB), and AMB deoxycholate (D-AMB) was studied in a rabbit model. D-AMB (1 mg\/kg of body weight\/day), ABLC (5 mg\/kg\/day), or L-AMB (5 mg\/kg\/day) was given intravenously to rabbits as a single dose or as repeated daily doses on 7 consecutive days after induction of unilateral uveitis by intravitreal injection of endotoxin. AMB concentrations in aqueous humor, vitreous humor, and plasma were determined by high-pressure liquid chromatography 16 h after administration of a single dose or 24 h after the last of seven doses. After single-dose administration, L-AMB achieved at least eightfold-higher AMB concentrations in the aqueous of inflamed eyes than ABLC or D-AMB (1.21 \u00b1 0.58 \u03bcg\/ml versus 0.14 \u00b1 0.04 and 0.11 \u00b1 0.09 \u03bcg\/ml, respectively). At that time point no drug was detectable in the vitreous. After 7 days of treatment, the concentration of AMB in the vitreous was higher after treatment with L-AMB (0.47 \u00b1 0.21 \u03bcg\/ml) than after treatment with ABLC (0.27 \u00b1 0.18 \u03bcg\/ml) and D-AMB (0.16 \u00b1 0.04 \u03bcg\/ml). Similarly, AMB concentration in the aqueous was higher after repeated doses of L-AMB (0.73 \u00b1 0.43 \u03bcg\/ml) than after repeated doses of ABLC (0.03 \u00b1 0.02 \u03bcg\/ml) or D-AMB (0.13 \u00b1 0.06 \u03bcg\/ml). No AMB was detected in noninflamed eyes. Following systemic administration, AMB distribution to the eye is inflammation dependent and occurs sequentially, first to the aqueous and then to the vitreous. Compared to D-AMB and ABLC, L-AMB reaches higher drug concentrations in both ocular compartments.<\/jats:p>","DOI":"10.1128\/aac.46.12.3719-3723.2002","type":"journal-article","created":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T20:02:26Z","timestamp":1037390546000},"page":"3719-3723","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":55,"title":["Ocular Distribution of Intravenously Administered Lipid Formulations of Amphotericin B in a Rabbit Model"],"prefix":"10.1128","volume":"46","author":[{"given":"David","family":"Goldblum","sequence":"first","affiliation":[{"name":"Department of Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Rohrer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology"},{"name":"Department of Clinical Pharmacology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice E.","family":"Frueh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regula","family":"Theurillat","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Thormann","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zimmerli","sequence":"additional","affiliation":[{"name":"and Institute for Infectious Diseases, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.3.518"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.834-840.2002"},{"key":"e_1_3_2_4_2","first-page":"51231","volume":"9","year":"1996","unstructured":"Brajtburg, J., and J. Bolard. 1996. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev.9:51231.","journal-title":"Clin. Microbiol. Rev."},{"key":"e_1_3_2_5_2","first-page":"666","volume":"97","year":"1990","unstructured":"Brod, R. D., H. W. Flynn, Jr., J. G. Clarkson, S. C. Pflugfelder, W. W. Culbertson, and D. Miller. 1990. Endogenous Candida endophthalmitis. Management without intravenous amphotericin B. Ophthalmology97:666-672.","journal-title":"Management without intravenous amphotericin B. Ophthalmology"},{"key":"e_1_3_2_6_2","first-page":"361","volume":"179","year":"1994","unstructured":"Carlson, M. A., and R. E. Condon. 1994. Nephrotoxicity of amphotericin B. J. Am. Coll. Surg.179:361-381.","journal-title":"J. Am. Coll. Surg."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3928\/1542-8877-19970301-03","volume":"28","year":"1997","unstructured":"Essman, T. F., H. W. Flynn, Jr., W. E. Smiddy, R. D. Brod, T. G. Murray, J. L. Davis, P. E. Rubsamen. 1997. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg. Lasers28:185-194.","journal-title":"Ophthalmic Surg. Lasers"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/infdis\/147.1.164","volume":"147","year":"1983","unstructured":"Fisher, J. F., A. T. Taylor, J. Clark, R. Rao, and A. Espinel-Ingroff. 1983. Penetration of amphotericin B into the human eye. J. Infect. Dis.147:164.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_9_2","first-page":"221","volume":"213","year":"1980","unstructured":"Forrester, J. V., B. V. Worgul, and G. R. Meriam. 1980. Endotoxin-induced uveitis in the rat. Albrecht von Graefes Arch. Klein. Ophthalmol.213:221-233.","journal-title":"Klein. Ophthalmol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.2.356"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.2.308"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00003226-200011000-00019","volume":"19","year":"2000","unstructured":"Goldblum, D., B. E. Frueh, S. Zimmerli, and M. B\u00f6hnke. 2000. Treatment of post-keratitis Fusarium endophthalmitis with amphotericin B lipid complex. Cornea19:853-857.","journal-title":"Cornea"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/clinids\/22.Supplement_2.S166","volume":"22","year":"1996","unstructured":"Graybill, J. R. 1996. The future of antifungal therapy. Clin. Infect. Dis.22:S166-178.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archopht.1965.00970030771004","volume":"73","year":"1965","unstructured":"Green, W. R., J. E. Bennett, and R. D. Goos. 1965. Ocular penetration of amphotericin B. Arch. Ophthalmol.73:769-775.","journal-title":"Arch. Ophthalmol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/315643"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60129-5"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.2.486"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.1.133"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/exer.1993.1036","volume":"56","year":"1993","unstructured":"Kulkarni, P. S., and M. Mancino. 1993. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp. Eye Res.56:275-279.","journal-title":"Exp. Eye Res."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.4.713"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02713688508999978","volume":"4","year":"1985","unstructured":"O'Day, D. M., W. S. Head, R. D. Robinson, W. H. Stern, and J. M. Freeman. 1985. Intraocular penetration of systemically administered antifungal agents. Curr. Eye Res.4:131-134.","journal-title":"Curr. Eye Res."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/33.1.73","volume":"33","year":"1994","unstructured":"Perfect, J. R., and K. A. Wright. 1994. Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis. J. Antimicrob. Chemother.33:73-81.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_23_2","first-page":"469","volume":"92","year":"1995","unstructured":"Pleyer, U., J. Grammer, J. H. Pleyer, P. Kosmidis, D. Friess, K. H. Schmidt, H. J. Thiel. 1995. Amphotericin B Wirkspiegel in der Cornea. Ophthalmologie92:469-475.","journal-title":"Ophthalmologie"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2165\/00002018-199005020-00003","volume":"5","year":"1990","unstructured":"Sabra, R., and R. A. Branch. 1990. Amphotericin B nephrotoxicity. Drug Safety5:94-108.","journal-title":"Drug Safety"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004397-199603630-00014","volume":"36","year":"1996","unstructured":"Samiy, N., and D. J. D'Amico. 1996. Endogenous fungal endophthalmitis. Int. Ophthalmol. Clin.36:147-162.","journal-title":"Int. Ophthalmol. Clin."},{"key":"e_1_3_2_26_2","first-page":"66","volume":"9","year":"1998","unstructured":"Smiddy, W. E. 1998. Treatment outcomes of endogenous fungal endophthalmitis. Curr. Opin. Ophthalmol.9:66-70.","journal-title":"Curr. Opin. Ophthalmol."},{"key":"e_1_3_2_27_2","unstructured":"Tester-Dalderup C. B. M. 1996. Antifungal drugs p. 774-779. In M. N. G. Dukes (ed.) Meyler's side effects of drugs 13th ed. Elsevier Science BV Amsterdam The Netherlands."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/517775","volume":"28","year":"1999","unstructured":"Virata, S. R., J. A. Kylstra, J. C. Brown, D. A. Wohl, and M. S. Cohen. 1999. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B. Clin. Infect. Dis.28:1177-1178.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_29_2","first-page":"467","volume":"38","year":"1988","unstructured":"Walsh, T. J., J. Bacher, and P. A. Pizzo. 1988. Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Lab. Anim. Sci.38:467-471.","journal-title":"Lab. Anim. Sci."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1086\/514704"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3719-3723.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.12.3719-3723.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:35:56Z","timestamp":1645464956000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.12.3719-3723.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1128\/AAC.46.12.3719-3723.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.12.3719-3723.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"2002-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}